Recently, immunohistochemical staining techniques employing an anti-human GPER monoclonal antibody (20H15L21) revealed, among 31 tumor entities, GPER protein expression in human renal, hepatocellular, and pancreatic tumors [149]. The gene discussed is GPER1; the disease is pancreatic neoplasm.